BioLyo Technologies

BioLyo Technologies is a Belgium-based life sciences services company focused on process and analytical development for Live Bacterial Products, including live vaccines and live biotherapeutic products. The company was spun out of ILiAD Biotechnologies in 2020 and operates as a wholly owned subsidiary supporting both internal and third-party programs. BioLyo specializes in media optimization, fermentation and harvest strategies, pre- and post-lyophilization formulation, process characterization, and quality control testing for bacterial live biologics. Its capabilities are designed to bridge discovery through clinical development and to support transfer into GMP manufacturing. The company appears to function primarily as a specialized CDMO/service provider rather than a therapeutics developer with a disclosed proprietary multi-asset pipeline.